Marc R Schneebaum Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marc R Schneebaum.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marc R Schneebaum. Marc R Schneebaum is Director in GENVEC INC ($GNVC) and Chief Financial Officer in SYNTA PHARMACEUTICALS CORP ($SNTA) and SVP and CFO in SYNTA PHARMACEUTICALS CORP ($SNTA).
Latest Insider Trading Transactions of Marc R Schneebaum
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | A | 119.49 | 32,000 | 3,823,680 | 32,000 | |
| Mar 05 2020 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | A | 91.79 | 32,000 | 2,937,280 | 32,000 | |
| Mar 11 2019 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | A | 127.96 | 28,000 | 3,582,880 | 28,000 | |
| Jun 13 2018 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | M | 61.60 | 2,734 | 168,414 | 1,640 | |
| Jun 13 2018 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | M | 99.75 | 5,223 | 520,994 | 1,205 | |
| Jun 13 2018 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Sell | S | 287.46 | 10,099 | 2,903,059 | 41,668 | 51.8 K to 41.7 K (-19.51 %) |
| Jun 13 2018 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Buy | M | 61.60 | 2,734 | 168,414 | 51,767 | 49 K to 51.8 K (+5.58 %) |
| Jun 13 2018 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Buy | M | 99.75 | 5,223 | 520,994 | 49,033 | 43.8 K to 49 K (+11.92 %) |
| Mar 05 2018 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | A | 124.45 | 28,000 | 3,484,600 | 28,000 | |
| Jun 20 2017 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | M | 3.80 | 1,500 | 5,700 | 0 | |
| Jun 20 2017 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Sell | D | 0.00 | 8,257 | 0 | 0 | 8.3 K to 0 (-100.00 %) |
| Jun 20 2017 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Payment of Exercise | F | 7.19 | 793 | 5,702 | 8,257 | 9.1 K to 8.3 K (-8.76 %) |
| Jun 20 2017 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Buy | M | 3.80 | 1,500 | 5,700 | 9,050 | 7.6 K to 9.1 K (+19.87 %) |
| Mar 06 2017 | SNTA | MADRIGAL PHARMACEU ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | A | 15.80 | 27,300 | 431,340 | 27,300 | |
| Oct 24 2016 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 0.38 | 15,000 | 5,700 | 15,000 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | Chief Financial Off ... | Option Exercise | A | 9.45 | 91,876 | 868,228 | 91,876 | |
| Jul 26 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | Chief Financial Off ... | Grant | A | 0.00 | 22,969 | 0 | 42,277 | 19.3 K to 42.3 K (+118.96 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Payment of Exercise | F | 9.48 | 8,548 | 81,035 | 19,308 | 27.9 K to 19.3 K (-30.69 %) |
| Jul 22 2016 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Grant | A | 0.00 | 25,714 | 0 | 27,856 | 2.1 K to 27.9 K (+1,200.47 %) |
| Nov 16 2015 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 1.95 | 15,000 | 29,250 | 15,000 | |
| Oct 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Option Exercise | A | 1.76 | 153,100 | 269,456 | 153,100 | |
| Sep 05 2013 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Grant | A | 0.00 | 75,000 | 0 | 75,500 | 500 to 75.5 K (+15,000.00 %) |
| Jul 13 2012 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 2.38 | 15,000 | 35,700 | 15,000 | |
| Jun 16 2011 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 2.82 | 1,500 | 4,230 | 1,500 | |
| Jun 18 2010 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 0.53 | 15,000 | 7,950 | 15,000 | |
| Jun 19 2009 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 0.82 | 15,000 | 12,359 | 15,000 | |
| Jun 17 2008 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 1.47 | 15,000 | 22,050 | 15,000 | |
| Apr 10 2008 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Buy | P | 1.98 | 3,338 | 6,609 | 5,000 | 1.7 K to 5 K (+200.84 %) |
| Apr 10 2008 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Buy | P | 1.98 | 1,662 | 3,291 | 1,662 | 0 to 1.7 K |
| Jun 15 2007 | GNVC | GENVEC INC | Schneebaum Marc R | Director | Option Exercise | A | 2.83 | 15,000 | 42,450 | 15,000 |
Page: 1